Skip to main content
Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: Targeting of anti-citrullinated protein/peptide antibodies in rheumatoid arthritis using peptides mimicking endogenously citrullinated fibrinogen antigens

Fig. 1

a. Percentage of responses among tested patients. Immune reactivity (%) against the respective peptide in sera from CCP2-positive patients. Positive immune reactivity (%) (dark grey) against each individual citrullinated fibrinogen peptide in sera from CCP2-positive patients; light gray represents negative immune response (%) against each individual citrullinated peptide in CCP2-positive sera tested. b. Relative frequency (%) of patient sera reacting to one, two, three, or four citrullinated fibrinogen peptides

Back to article page